Future of drugs-Diabetes_Bexagliflozin

This series will take you through the future of drugs. Which drugs are in the pipeline of which company, which clinical phase are they in during trials? We have all the answers.               

We are going to start with diabetes since it is one of the biggest monsters plaguing India since decades.  According to statistics and surveys, India has the most number of diabetics in the world.

Hence, in this series, we are going to take you through the most promising few candidates against diabetes in the future. These drugs might shape the Pharma market for diabetes and we can be rest assured that we might have newer drugs for this deadly disease.

Drug Name
Bexagliflozin
Structure
ChemSpider 2D Image | bexagliflozin | C24H29ClO7
Drug Code
EGT 0001442
Synonym
THR-1442
Molecular Formula
C24H29ClO7
Innovator
Theracos (US based company)
Condition
Type 2 Diabetes Mellitus
Mechanism of Action
Sodium-glucose transporter 2 inhibitor
Clinical Phase
III  in USA


Comments

Popular posts from this blog

China-India joint summit discusses bilateral trade to improve pharma industry

PHYTOCON 2018 - Commercialization of medicinal plant products: Lab techniques to trade_14 April 2018